Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
Completed trial evaluating a multimodal deep learning model that predicts prognosis in pancreatic adenocarcinoma. The study was conducted by…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors [NA]
A completed clinical trial comparing robotic versus open pancreaticoduodenectomy for pancreatic and periampullary tumors.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating telotristat ethyl for weight stability in advanced pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion [Phase 1]
Bristol-Myers Squibb is conducting a Phase 1 trial of MRTX1719 in MTAP-deleted solid tumors, including mesothelioma, non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy [NA]
This clinical trial update describes PROACTIVE, a study assessing surgical resection outcomes after neoadjuvant chemotherapy in locally adva…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma [Phase 1]
Phase 1 trial evaluated CPI-613 (Devimistat) in combination with chemoradiation for pancreatic adenocarcinoma. The study has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial investigating Gemcitabine and nab-paclitaxel in combination with the TheraBionic P1 device for metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region [NA]
This document provides an update on a completed clinical trial evaluating respiratory-gated SBRT for pancreatic adenocarcinoma and periampul…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety, tolerability, and efficacy of the modified FOLFIRINOX regimen with or without BNT321 as adjuvant ther…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma [Phase 1]
This document reports a completed Phase 1 exploratory platform trial evaluating immunotherapy combinations with chemotherapy for patients wi…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and tolerability of combining epigenetic and immunomodulating drugs with standard chemot…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]
Phase 2 trial evaluating high-dose vitamin C (ascorbate) for pancreatic cancer has completed (PACMAN 2.1).
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer [Phase 3]
Phase 3 trial update evaluating vitamin C to treat chemotherapy-related anemia in metastatic pancreatic adenocarcinoma; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?
Clinical trial update evaluating whether the 3D-PANC MSP model better assesses neoadjuvant treatment response in pancreatic adenocarcinoma t…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer [Phase 1]
A Phase 1 neoadjuvant trial evaluating paricalcitol to modify the tumor microenvironment in resectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating hydroxychloroquine in combination with gemcitabine and Abraxane in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer [NA]
A clinical trial evaluating a medical food for dietary management in advanced or metastatic pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: 9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma [Phase 2]
This Phase 2 trial update reports results for the combination of 9-ING-41, retifanlimab, gemcitabine, and nab-paclitaxel in advanced pancrea…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study [Phase 2]
Phase 2 trial evaluating total intravenous anesthesia after cancer surgery (TIVACS) in pancreatic adenocarcinoma was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases [Phase 2]
Phase 2 clinical trial update of hepatic artery infusion with floxuridine for pancreatic adenocarcinoma with liver metastases; the study is …
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study of IMM-6-415 in Ras/RAF-mutant solid tumors, including pancreatic ade…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers Nano-SMART, a nanoparticle therapy with MR-guided SBRT being studied in centrally located lung tumors and …